Products April 8, 2010

ProShares Launches Leveraged and Inverse Biotechnology ETFs

April 8, 2010 (PLANSPONSOR.com) – ProShares has launched ETFs with leveraged and inverse exposure to the biotechnology sector.
Reported by
Add as a preferred source on Google

The Ultra Nasdaq Biotechnology (BIB) and UltraShort Nasdaq Biotechnology (BIS), will listed on NASDAQ Thursday.

The Ultra Nasdaq Biotechnology seeks investment results that correspond to twice (200%) the performance of the NASDAQ Biotechnology Index for a single day, before fees and expenses, while the UltraShort Nasdaq Biotechnology is built to produce 200% of the inverse performance of the NASDAQ Biotechnology Index for a single day, before fees and expenses.

Never miss a story — sign up for PLANSPONSOR newsletters to keep up on the latest retirement plan benefits news.

More information is at http://www.proshares.com.

«